The SA Journal Diabetes & Vascular Disease Vol 12 No 1 (July 2015)

20 / 48

REVIEW SA JOURNAL OF DIABETES & VASCULAR DISEASE
18 VOLUME 12 NUMBER 1 • JULY 2015
17. Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated
without viral integration. Science 2008;322:945-49.
science.1162494
18. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells
from adult fibroblasts by defined factors. Cell 2007; 131:861-72. .
org/10.1016/j.cell.2007.11.019
19. Klusakova I, Dubovy P. Experimental models of peripheral neuropathic pain
based on traumatic nerve injuries – an anatomical perspective. Ann Anat
2009;191:248-59. 02.007
20. Odd-Gehir B. Predictive validity of behavioural animal models for chronic
pain. Br J Pharmacol 2011;164:1195-206.
5381.2011.01300.x
21. Le Bars D, Gozariu M, Cadden SW,et al. Animal models of nociception. Pharmacol
Rev 2001;53:597-652.
22. Kawasaki-Yatsugi S, Nagakura Y, Ogino S, et al. Automated measurement of
spontaneous pain-associated limb movement and drug efficacy evaluation in
a rat model of neuropathic pain. Eur J Pain 2012;16:1426-36. .
org/10.1002/j.1532-2149.2012.00142.x
23. Braz JM, Sharif-Naeini R, Vogt D, et al. Forebrain GABAergic neuron precursors
integrate into adult spinal cord and reduce injury-induced neuropathic pain.
Neuron 2012;74:663-75.
24. Vit JP, Ohara PT, Sundberg C, et al. Adenovector GAD65 gene delivery into the rat
trigeminal ganglion produces orofacial analgesia. Mol Pain 2009;5:42.
25. Hao S, Mata M, Wolfe D, et al. Gene transfer of glutamic acid decarboxylase
reduces neuropathic pain. Ann Neurol 2005;57:914-18.
ana.20483
26. Eaton MJ, Plunkett JA, Martinez MA, et al. Transplants of neuronal cells
bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell
Transplant 1999;8:87-101.
27. Mackie M, Hughes DI, Maxwell DJ, et al. Distribution and colocalisation
of glutamate decarboxylase isoforms in the rat spinal cord. Neuroscience
2003;119:461-72. 03)00174-X
28. De Koninck Y. Altered chloride homeostasis in neurological disorders: a
new target. Curr Opin Pharmacol 2007;7:93-9.
coph.2006.11.005
29. Price TJ, Cervero F, de Konnick Y. Chloride regulation in the pain pathway. Brain
Res 2009;60:149-70.
30. Hendricks WA, Pak ES, Owensby JP, et al. Predifferentiated embryonic stem cells
prevent chronic pain behaviours and restore sensory function following spinal
cord injury in mice. Mol Med 2006;12:34-46.
00014.Hendricks
31. Hains BC, Johnson KM, Hulseboch CE. Engraftment of serotonergic precursors
enhances locomotor function and attenuates chronic central pain behaviour
following spinal hemisection injury in the rat. Exp Neurol 2001;171:361-78.
32. FranchiS,ValsecchiA,BorsaniE,etal.Intravenousneuralstemcellsabolishnociceptive
hypersensitivity and trigger nerve regeneration in experimental neuropathy. Pain
2012;153(4):850-61.
33. Martucci C, Trovato AE, Costa B, et al. The purinergic antagonist PPADS reduces
pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS
overproduction incentralandperipheralnervoussystemafterperipheral neuropathy
in mice. Pain 2008;137:81-95.
34. Ruff CA, Wilcox JT, Fehlings MG. Cell-based transplantation strategies to
promote plasticity following spinal cord injury. Exp Neurol 2012;235:78-90.
02.010
35. Harris JA. Using c-fos as a neural marker of pain. Brain Res Bull 1998; 45:1-8.
97)00277-3
36. Cahill CM, Coderre TJ. Attenuation of hyperalgesia in a rat model of neuropathic
pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist.
Pain 2002; 95:277-85. 01)00410-9
37. Coronel MF, Musolino PL, Brumovsky PR, et al. Bone marrow stromal cells
attenuate injury-induced changes in galanin, NPY and NPY Y1-receptor expression
after a sciatic nerve constriction. Neuropeptides 2009;43:125-32. .
org/10.1016/j.npep.2008.12.003
38. Liu HX, Hokfelt T. The participation in galanin in pain processing at the spinal
level. Trends Pharamacol Sci 2002;23:468-74.
6147(02)02074-6
39. Pluchino S, Gritti A, Blezer E, et al. Human neural stem cells ameliorate auto
immune encephalomyelitis in non-human primates. Ann Neurol 2009;66:343-54.
40. Siniscalco D, Giordano C, Galderisi U, et al. Intra-brain microinjection of human
mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci
2012;67:655-69.
41. Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, et al. Delayed post-ischaemic
neuroprotection following neural stem cell transplantation involves multiple
mechanisms. Brain 2009;132:2239-51.
42. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, et al. Synergistic effects of
transplanted adult neural stem / progenitor cells, chondroitinase, and growth
factors promote functional repair and plasticity of chronically injured spinal
cord. J Neurosci 2010;30:1657-76.
09.2010
43. Hofstetter CP, Holmstrom N, Lilja JA, et al. Allodynia limits the usefulness of
intraspinal neural stem cell grafts; directed differentiation improves outcome.
Nat Neurosci 2005;8:346-53.
44. Pendharkar AV, Chua JY, Andres RH et al. Biodistribution of neural stem cells after
intravascular therapy for hypoxic-ischaemia. Stroke 2010;41: 2064-70. http://
45. Klein S, Svendsen CN. Stem cells in the injured spinal cord: reducing the pain and
increasing the gain. Nature Neurosci 2005; 8:259-60.
nn0305-259
46. Winkler RA, Fricker MA, Gates MA, et al. Incorporation and glial differentiation
of mouse EGF-responsive neural progenitor cells after transplantation into the
embryonic rat brain. Mol Cell Neurosci 1998;11: 99-116.
47. Sommer L, Ma Q, Anderson DJ. Neurogenins, a novel family of atonal related
bHLH transcription factors, are putative mammalian neuronal determination
genes that reveal progenitor cell heterogeneity in the developing CNS and PNS.
Mol Cell Neurosci 1996;8:221-41.
48. Brown A, Ricci MJ, Weaver LC. NGF message and protein distribution in the
injured rat spinal cord. Exp Neurol 2004;188:115-27.
expneurol.2004.03.017
49. Klass M, Gavrikov V, Drury D et al. Intravenous mononuclear marrow cells
reverse neuropathic pain from experimental mononeuropathy. Anesth Analg
2007;104:944-48. 0000258021.03211.d0
50. Siniscalco D, Giordano C, Galderisi U, et al. Long-lasting effects of human
mesenchymal stem cell systemic administration on pain-like behaviours, cellular,
and biomolecular modifications in neuropathic mice. Frontiers in Integrative
Neuroscience 2011;5:1-10. fnint.2011.00079
51. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type
of alternatively activated macrophages. Exp Hematol 2009;37: 1445-53. http://
52. Ankrum I, Karp J. Mesenchymal stem cell therapy: two steps forward, one step back.
Trends Mol Med 2010;16:203-09.
53. Jain M, Armstrong RJ, Tyers P, et al. GABAergic immunoreactivity is predominant
in neurons derived from expanded human neural precursor cells in vitro. Exp
Neurol 2003;182:113-23. 03)00055-4
54. Mukhida K, Mendez I, McLeod M, et al. Spinal GABAergic transplants
attenuate mechanical allodynia in a rat model of neuropathic pain. Stem Cells
2007;25:2874-85.
55. Amariglio N, Hirshberg A, Scheithauer BW, et al. ‘Donor-derived brain tumor
following neural stem cell transplantation in an ataxia telangiectasia patient.’
PLoS Medicine 2009;17:e:1000029.
56. Herrera MB, Fonsato V, Gatti S, et al . Human liver stem cell-derived microvesicles
accelerate hepatic regeneration in hepatectomised rats. J Cell Mol Med
2010;14:1605-18.